Table 1.
Demographic data and descriptive statistics for all patients included: Primary Open Angle Glaucoma (POAG), Pseudoexfoliation Glaucoma (XFG), Myopia associated Glaucoma (Myopic), Uveitic secondary Glaucoma (Uveitic), Steroid-induced Glaucoma (Steroid), Normal Tension Glaucoma (NTG), Ocular Hypertension (OHT), Dysgenetic Glaucoma (Dysgenetic), Pigmentary Glaucoma (Pigment), Traumatic secondary Glaucoma (Trauma) (*) marks glaucoma subgroups that have not been included for further statistical analysis due to small group size
| POAG | XFG | Myopic | Uveitic | Steroid | NTG | OHT | Dysgenetic | Pigment | Trauma | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of patients included | n | 261 | 173 | 31 | 22 | 19 | 13 | 13 | 13 | 8 | 4 |
| Age | [years] | 70.6 ± 10.6 | 74.1 ± 9.3 | 59.6 ± 9.5 | 44.2 ± 16.2 | 53.4 ± 15.3 | 72.0 ± 7.0 | 64.8 ± 10.8 | 46.3 ±12.1 | 53.5 ± 10.6 | 46.3 ± 30.5 |
| Female | n | 137 (52 %) | 96 (55 %) | 20 (65 %) | 10 (45 %) | 7 (37 %) | 11 (85 %) | 7 (54 %) | 4 (31 %) | 4 (50 %) | 1 (25 %) |
| Cup-disc-ratio | 0.7 ± 0.1 | 0.72 ± 0.2 | 0.8 ± 0.1 | 0.7 ± 0.2 | 0.6 ± 0.2 | 0.8 ± 0.1 | 0.5 ± 0.1 | 0.6 ± 0.2 | 0.7 ± 0.2 | 0.4 ± 0.3 | |
| Phakic at time of surgery | n | 78 (31 %) | 57 (34 %) | 13 (42 %) | 9 (43 %) | 10 (56 %) | 7 (54 %) | 6 (50 %) | 10 (83 %) | 6 (75 %) | 2 (50 %) |
| Pseudophakic at time of surgery | n | 72 (28 %) | 43 (25 %) | 13 (42 %) | 9 (43 %) | 7 (39 %) | 2 (15 %) | 2 (17 %) | 2 (17 %) | 4 (50 %) | 2 (50 %) |
| Combined surgery phaco + trabectome | n | 105 (40 %) | 70 (41 %) | 5 (16 %) | 3 (14 %) | 1 (6 %) | 4 (31 %) | 4 (33 %) | 0 | 0 | 0 |
| Surgery on both eyes | n | 73 (28 %) | 29 (17 %) | 10 (32 %) | 5 (23 %) | 4 (21 %) | 6 (46 %) | 5 (38 %) | 7 (54 %) | 1 (12 %) | 0 |
| Mean IOP preop. | [mmHg] | 24.2 ± 5.5 | 25.0 ± 5.9 | 24.8 ± 4.4 | 31.7 ± 10.7 | 32.1 ± 10.3 | 18.9 ± 3.6 | 23.8 ± 8.0 | 26.3 ± 5.5 | 23.2 ± 5.3 | 27.0 ± 12.0 |
| Mean medication preop. | n | 2.1 ± 1.3 | 2.0 ± 1.2 | 2.2 ± 1.1 | 1.7 ± 1.3 | 1.6 ± 1.2 | 2.7 ± 1.2 | 1.7 ± 1.4 | 2.0 ± 1.2 | 2.0 ± 1.3 | 1.8 ± 1.3 |
| Mean follow-up | [days] | 204.1 ± 237.8 | 200.1 ± 278.5 | 235.9 ± 286.7 | 114.1 ± 149.6 | 185.6 ± 249.7 | 426.5 ± 461.9 | 186.6 ± 220.9 | 291.6 ± 422.5 | 213.2 ± 164.2 | 409.1 ± 261.7 |
| Mean IOP postop. | [mmHg] | 18.2 ± 6.1 | 17.6 ± 8.2 | 18.8 ± 6.8 | 25.7 ± 11.9 | 20.9 ± 8.9 | 15.4 ± 4.0 | 17.5 ± 6.2 | 15.7 ± 6.6 | 19.1 ± 6.9 | 25.5 ± 17.2 |
| Mean medication postop. | n | 1.2 ± 1.1 | 1.1 ± 1.1 | 1.3 ± 1.2 | 1.6 ± 1.1 | 1.3 ± 1.1 | 1.5 ± 1.3 | 0.9 ± 0.6 | 1.5 ± 1.1 | 2.1 ± 1.3 | 1.3 ± 1.5 |
| * | * | * | * | * | * | * | * |